Copyright Reports & Markets. All rights reserved.

Global Breast Cancer Screening Market Growth 2019-2024

Buy now

Table of Contents

    2019-2024 Global Breast Cancer Screening Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Breast Cancer Screening Consumption 2014-2024
        • 2.1.2 Breast Cancer Screening Consumption CAGR by Region
      • 2.2 Breast Cancer Screening Segment by Type
        • 2.2.1 Mammography Screening
        • 2.2.2 Breast Magnetic Resonance Imaging (MRI) Screening
        • 2.2.3 Breast Ultrasound Screening
      • 2.3 Breast Cancer Screening Consumption by Type
        • 2.3.1 Global Breast Cancer Screening Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Breast Cancer Screening Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Breast Cancer Screening Sale Price by Type (2014-2019)
      • 2.4 Breast Cancer Screening Segment by Application
        • 2.4.1 Hospital
        • 2.4.2 Clinic
      • 2.5 Breast Cancer Screening Consumption by Application
        • 2.5.1 Global Breast Cancer Screening Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Breast Cancer Screening Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Breast Cancer Screening Sale Price by Application (2014-2019)

      3 Global Breast Cancer Screening by Players

      • 3.1 Global Breast Cancer Screening Sales Market Share by Players
        • 3.1.1 Global Breast Cancer Screening Sales by Players (2017-2019)
        • 3.1.2 Global Breast Cancer Screening Sales Market Share by Players (2017-2019)
      • 3.2 Global Breast Cancer Screening Revenue Market Share by Players
        • 3.2.1 Global Breast Cancer Screening Revenue by Players (2017-2019)
        • 3.2.2 Global Breast Cancer Screening Revenue Market Share by Players (2017-2019)
      • 3.3 Global Breast Cancer Screening Sale Price by Players
      • 3.4 Global Breast Cancer Screening Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Breast Cancer Screening Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Breast Cancer Screening Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Breast Cancer Screening by Regions

      • 4.1 Breast Cancer Screening by Regions
        • 4.1.1 Global Breast Cancer Screening Consumption by Regions
        • 4.1.2 Global Breast Cancer Screening Value by Regions
      • 4.2 Americas Breast Cancer Screening Consumption Growth
      • 4.3 APAC Breast Cancer Screening Consumption Growth
      • 4.4 Europe Breast Cancer Screening Consumption Growth
      • 4.5 Middle East & Africa Breast Cancer Screening Consumption Growth

      5 Americas

      • 5.1 Americas Breast Cancer Screening Consumption by Countries
        • 5.1.1 Americas Breast Cancer Screening Consumption by Countries (2014-2019)
        • 5.1.2 Americas Breast Cancer Screening Value by Countries (2014-2019)
      • 5.2 Americas Breast Cancer Screening Consumption by Type
      • 5.3 Americas Breast Cancer Screening Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Breast Cancer Screening Consumption by Countries
        • 6.1.1 APAC Breast Cancer Screening Consumption by Countries (2014-2019)
        • 6.1.2 APAC Breast Cancer Screening Value by Countries (2014-2019)
      • 6.2 APAC Breast Cancer Screening Consumption by Type
      • 6.3 APAC Breast Cancer Screening Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Breast Cancer Screening by Countries
        • 7.1.1 Europe Breast Cancer Screening Consumption by Countries (2014-2019)
        • 7.1.2 Europe Breast Cancer Screening Value by Countries (2014-2019)
      • 7.2 Europe Breast Cancer Screening Consumption by Type
      • 7.3 Europe Breast Cancer Screening Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Breast Cancer Screening by Countries
        • 8.1.1 Middle East & Africa Breast Cancer Screening Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Breast Cancer Screening Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Breast Cancer Screening Consumption by Type
      • 8.3 Middle East & Africa Breast Cancer Screening Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Breast Cancer Screening Distributors
      • 10.3 Breast Cancer Screening Customer

      11 Global Breast Cancer Screening Market Forecast

      • 11.1 Global Breast Cancer Screening Consumption Forecast (2019-2024)
      • 11.2 Global Breast Cancer Screening Forecast by Regions
        • 11.2.1 Global Breast Cancer Screening Forecast by Regions (2019-2024)
        • 11.2.2 Global Breast Cancer Screening Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Breast Cancer Screening Forecast by Type
      • 11.8 Global Breast Cancer Screening Forecast by Application

      12 Key Players Analysis

      • 12.1 Hologic
        • 12.1.1 Company Details
        • 12.1.2 Breast Cancer Screening Product Offered
        • 12.1.3 Hologic Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Hologic News
      • 12.2 GE Healthcare
        • 12.2.1 Company Details
        • 12.2.2 Breast Cancer Screening Product Offered
        • 12.2.3 GE Healthcare Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 GE Healthcare News
      • 12.3 Siemen Healthineers
        • 12.3.1 Company Details
        • 12.3.2 Breast Cancer Screening Product Offered
        • 12.3.3 Siemen Healthineers Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Siemen Healthineers News
      • 12.4 Philips Healthcare
        • 12.4.1 Company Details
        • 12.4.2 Breast Cancer Screening Product Offered
        • 12.4.3 Philips Healthcare Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Philips Healthcare News
      • 12.5 Canon Medical
        • 12.5.1 Company Details
        • 12.5.2 Breast Cancer Screening Product Offered
        • 12.5.3 Canon Medical Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Canon Medical News
      • 12.6 Fujifilm
        • 12.6.1 Company Details
        • 12.6.2 Breast Cancer Screening Product Offered
        • 12.6.3 Fujifilm Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Fujifilm News
      • 12.7 Metaltronica
        • 12.7.1 Company Details
        • 12.7.2 Breast Cancer Screening Product Offered
        • 12.7.3 Metaltronica Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Metaltronica News
      • 12.8 Sino Medical-Device
        • 12.8.1 Company Details
        • 12.8.2 Breast Cancer Screening Product Offered
        • 12.8.3 Sino Medical-Device Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Sino Medical-Device News
      • 12.9 IMS Srl
        • 12.9.1 Company Details
        • 12.9.2 Breast Cancer Screening Product Offered
        • 12.9.3 IMS Srl Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 IMS Srl News

      13 Research Findings and Conclusion

      Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.
      A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.
      The top players cover Hitachi Medical Corporation, Siemen Healthineers, Philips Healthcare and GE Healthcare etc., which are playing important roles in global Breast Cancer Screening market.
      At present, global economy is fluctuant, and most countries take measures to stimulate the economy, especially in Rest of Asia, Europe, Australia and the resources providing countries, like Russia, Middle East, Brazil etc. In many fields, China is the largest consumer, but in the past several years, China's economic growth slows. The China government is reforming the economic structure, to release energy of economy. USA economy is relatively stable with low-speed-growth, but in future, it also is full of risk. In Southeast Asia, the economy also is fluctuated the economic base is comparatively unsubstantial, due to the exchange fluctuations. In India, although many people look to further increase in India, but the economic aggregate is too low and the infrastructure is behindhand and inefficient. In a long term, India will keep a stable and low growth in economy, due to its economic structure and bureaucratic system.
      On the other hand, the political factors, like government succession, security fears, trade dispute, domestic employment, even the regional military crisis, always affect the economic activity, country to country, corporation to country. So it needs us with deep insight, to analyze the prospect avoid risk, to grasp the opportunity and reduce losses.

      According to this study, over the next five years the Breast Cancer Screening market will register a 8.4% CAGR in terms of revenue, the global market size will reach US$ 2310 million by 2024, from US$ 1430 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Breast Cancer Screening business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Breast Cancer Screening market by product type, application, key manufacturers and key regions and countries.

      This study considers the Breast Cancer Screening value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Mammography Screening
      Breast Magnetic Resonance Imaging (MRI) Screening
      Breast Ultrasound Screening
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Hospital
      Clinic

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Hologic
      GE Healthcare
      Siemen Healthineers
      Philips Healthcare
      Canon Medical
      Fujifilm
      Metaltronica
      Sino Medical-Device
      IMS Srl

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Breast Cancer Screening consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Breast Cancer Screening market by identifying its various subsegments.
      Focuses on the key global Breast Cancer Screening manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Breast Cancer Screening with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Breast Cancer Screening submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now